|
CLYM Climb Bio Inc 1768446 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-13,722,000.00 |
| Balance Sheet |
|
Current Assets
|
$113,404,000.00 |
|
Assets
|
$152,372,000.00 |
|
Current Liabilities
|
$4,071,000.00 |
|
Liabilities
|
$4,287,000.00 |
|
Equity
|
$148,085,000.00 |
|
Shares Out
|
47768543.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-14,379,000.00 |
|
Investing Cash Flow
|
$-12,955,000.00 |
| Market Analysis |
Market Cap
|
$577,043,999.44 |
|
Price
|
$11.50 |
|
BVPS
|
3.10 |
|
PB
|
3.90 |
|
EPS
|
-0.20 |
|
FCF
|
$-19,024,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:28 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:24 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view CLYM documents filed with the SEC.
CLYM Filings
Clear
